Holen Sie sich die Stockscreener-App
24.77
3.90%
0.93
Handel nachbörslich:
24.54
-0.23
-0.93%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Weekly Market Update: Stocks Slide as Financials, Consumer Cyclicals Fall - Morningstar
Hims & Hers Stock Skyrockets Amid Novo Nordisk Partnership - StocksToTrade
Hims Shares Set for Record Week as New Novo Pact Fuels Optimism - Bloomberg.com
Hims & Hers (HIMS) Sees Analyst Optimism Following Novo Resolution - Insider Monkey
Selling pressure pushes Hims & Hers Health stock lower in today's trading - Traders Union
Hims shares set for record week as Novo partnership fuels optimism - Modern Healthcare
Barclays Raises PT on Hims & Hers Health (HIMS) Stock - Yahoo Finance
Hims shares set for best week on record after new Novo Nordisk deal - Investing.com
5 Best Day Trading Stocks to Buy Now - Insider Monkey
12 Most Shorted Stocks to Buy in 2026 - Insider Monkey
‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up - MedCity News
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - Yahoo Finance
Hims & Hers stock takes a major hit amid multiple investigations and target cuts - StocksToTrade
Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking - Yahoo Finance
Hims And Hers Benefits Aims To Deepen Member Loyalty And Engagement - simplywall.st
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Faces Investigation Amid Wegovy Sales Discontinuation - timothysykes.com
Hims & Hers Stock Jumps After Novo Nordisk Deal. What It Means for Drugmaker - TradingView
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - The Globe and Mail
Hims & Hers Health hires Kathryn Beiser as chief communications officer - Medical Marketing and Media
Should You Chase the Rally in Hims & Hers Stock Today? - Barchart.com
Is Hims & Hers Really the Growth Stock to Buy That It Appears? - Yahoo Finance
Hims & Hers Health And Novo Nordisk: A Corporate Remarriage That May Work Out Profitably (NYSE:HIMS) - Seeking Alpha
Why Hims & Hers Health (HIMS) Stock Is Surging In Thursday's Premarket - Benzinga
Hims & Hers Health stock continues rally, rises 7% in premarket trading - MSN
Obesity Drugs Are Getting Easier and Cheaper to Find - Bloomberg
Hims & Hers Health (HIMS) Stock Up 7% Premarket Thursday, On Track for Best Week Ever - CoinCentral
Trending tickers: Nebius Group, Hims & Hers, BMW, Savills and On The Beach - Yahoo Finance UK
Hims & Hers (HIMS) soars 10.3% on analyst upgrades, new deal - MSN
Hims & Hers revamps GLP-1 strategy with Novo Nordisk - TipRanks
JPMorgan Chase & Co. Significantly Reduces Stake in Hims & Hers Health Inc. - GuruFocus
Hims & Hers (HIMS) Soars 10.3% on Analyst Upgrades, New Deal - Insider Monkey
A Look At Novo Nordisk’s Valuation After Hims & Hers GLP 1 Distribution Agreement - simplywall.st
Lucid Tops The Most-Shorted Stock List—Here Are 9 More Short Targets - Benzinga
Hims & Hers Hires Ex-Eli Lilly Communications Chief Amid Obesity Drug Strategy Shift - GuruFocus
Hims & Hers Stock Skyrockets as Landmark Settlement with Novo Nordisk Ends Weight-Loss Drug War - FinancialContent
Hims & Hers C-suite shake-up, Stryker outage may be Iran-backed - Yahoo Finance
HIMS Stock Jumps 14% – Barclays Says Market Is Underestimating Opportunity From New Products - Stocktwits
3 Big Reasons to Love Hims & Hers Health (HIMS) - Yahoo Finance
HIMS Jumps 14.5% Following Strong Market Interest - GuruFocus
Hims & Hers: The Novo Nordisk Deal Changes Everything (NYSE:HIMS) - Seeking Alpha
Hims & Hers Brings In Lilly Communications Veteran - GuruFocus
Hims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
Barclays Raises Price Target for HIMS: Maintains Overweight Rati - GuruFocus
Hims & Hers Health Stock Is Surging Wednesday: What's Going On? - Benzinga
Hims & Hers Health (NYSE:HIMS) Shares Up 11.5% After Analyst Upgrade - MarketBeat
This Novo Nordisk Partnership Shows That HIMS Has All The Leverage (NYSE:HIMS) - Seeking Alpha
Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook - AOL.com
Can Novo Nordisk's Hims & Hers Deal Revive Its GLP-1 Momentum? - Yahoo! Finance Canada
Short Seller Who Bet Against Hims & Hers Now Says Its CEO 'Wiped The Floor' With Novo Nordisk - Stocktwits
Hims And Hers Taps Veteran Communicator To Shape GLP 1 Growth Story - simplywall.st
Investor relations - HIMS Investor Relations
Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Rating of "Hold" by Analysts - MarketBeat
HIMS Stock Just Exploded — But the Real Story Might Be the Novo Nordisk Deal - TS Avisen
Hims & Hers appoints Kathryn Beiser as communications chief - Investing.com
Hims & Hers Names Kathryn Beiser as Chief Communications Officer - HIMS Investor Relations
Hims Hires Ex-Lilly PR Chief as Its Weight-Loss Strategy Shifts - Bloomberg.com
Hims & Hers Expands Health Platform with Major Novo Nordisk Deal - StocksToTrade
Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track (NYSE:HIMS) - Seeking Alpha
Asset Manager Exits Shares of Hims & Hers Health - Yahoo Finance
What's Driving Attention Behind These Trending Stocks? MRVL, STRL, HIMS - Finviz
Hims & Hers Health Soars with Novo Nordisk Partnership Plans - timothysykes.com
Hims & Hers Stock Upgraded After Novo Nordisk Agreement. Why It Isn’t a Buy Yet. - Barron's
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal - MarketBeat
Hims and Hers Expands Consumer-Focused Digital Health Platform - TradingView
What's Fueling The Rise In Hims & Hers Health Stock Today? - Benzinga
1.15%
3.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):